Changes of Microrna Levels in Plasma of Patients with Rectal Cancer during Chemoradiotherapy
Authors:
- Peter JoPJPeter Jo
- Azadeh AzizianAAAzadeh Azizian
- Junius SalendoJSJunius Salendo
- Frank KramerFKFrank Kramer
- Markus BernhardtMBMarkus Bernhardt
- Hendrik A. WolffHWHendrik A. Wolff
- Jens GruberJGJens Gruber
- Marian GradeMGMarian Grade
- Tim BeißbarthTBTim Beißbarth
- B. Michael GhadimiBGB. Michael Ghadimi
- Jochen GaedckeJGJochen Gaedcke
Open Access
- 27 May 2017
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 18 (6) , 1140
Abstract
Since the response to chemoradiotherapy in patients with locally advanced rectal cancer is heterogeneous, valid biomarkers are needed to monitor tumor response. Circulating microRNAs are promising candidates, however analyses of circulating microRNAs in rectal cancer are still rare. 111 patients with rectal cancer and 46 age-matched normal controls were enrolled. The expression levels of 30 microRNAs were analyzed in 17 pre-treatment patients’ plasma samples. Differentially regulated microRNAs were validated in 94 independent patients. For 52 of the 94 patients a paired comparison between pre-treatment and post-treatment samples was performed. miR-17, miR-18b, miR-20a, miR-31, and miR-193a_3p, were significantly downregulated in pre-treatment plasma samples of patients with rectal cancer (p < 0.05). miR-29c, miR-30c, and miR-195 showed a trend of differential regulation. After validation, miR-31 and miR-30c were significantly deregulated by a decrease of expression. In 52 patients expression analyses of the 8 microRNAs in matched pre-treatment and post-treatment samples showed a significant decrease for all microRNAs (p < 0.05) after treatment. Expression levels of miR-31 and miR-30c could serve as valid biomarkers if validated in a prospective study. Plasma microRNA expression levels do not necessarily represent miRNA expression levels in tumor tissue. Also, expression levels of microRNAs change during multimodal therapy.Keywords
This publication has 45 references indexed in Scilit:
- The expression of microRNA-375 in plasma and tissue is matched in human colorectal cancerBMC Cancer, 2014
- Comparative RNA-sequencing analysis of myocardial and circulating small RNAs in human heart failure and their utility as biomarkersProceedings of the National Academy of Sciences, 2014
- Identification of a microRNA expression signature for chemoradiosensitivity of colorectal cancer cells, involving miRNAs-320a, -224, -132 and let7gRadiotherapy and Oncology, 2013
- Use of Research Biopsies in Clinical Trials: Are Risks and Benefits Adequately Discussed?Journal of Clinical Oncology, 2013
- Suppression of microRNA-31 increases sensitivity to 5-FU at an early stage, and affects cell migration and invasion in HCT-116 colon cancer cellsBMC Cancer, 2010
- Selective Release of MicroRNA Species from Normal and Malignant Mammary Epithelial CellsPLOS ONE, 2010
- MicroRNA expression after ionizing radiation in human endothelial cellsRadiation Oncology, 2010
- Predictive Factors of Pathologic Complete Response After Neoadjuvant Chemoradiation for Rectal CancerAnnals of Surgery, 2009
- Differential expression of microRNA species in human gastric cancer versus non‐tumorous tissuesJournal of Gastroenterology and Hepatology, 2009
- Prognostic Significance of Tumor Regression After Preoperative Chemoradiotherapy for Rectal CancerJournal of Clinical Oncology, 2005